Recurring Revenue

Search documents
Should Allot Stock Be in Your Portfolio Before Q2 Earnings?
ZACKS· 2025-08-13 18:10
Core Insights - Allot Ltd. (ALLT) is set to report its Q2 2025 results on August 14, with earnings expected to be breakeven compared to a loss of 2 cents in the same quarter last year [1] - The revenue consensus estimate for the upcoming quarter is $22.9 million, reflecting a 3.3% year-over-year increase [1][2] - The company has seen strong demand for its Smart and Tera III products, driven by multi-million-dollar agreements with tier-1 customers, which is expected to boost revenue and margins [6][8] Financial Estimates - The Zacks Consensus Estimate for Q2 2025 revenues is $22.9 million, with a year-over-year growth estimate of 3.34% [2] - For the next quarter (Q3 2025), the revenue estimate is $25.9 million, indicating an 11.45% growth [2] - The current year revenue estimate stands at $98.6 million, with a year-over-year growth of 6.95%, while the next year is projected at $125.7 million, reflecting a 27.48% increase [2] Earnings Projections - The earnings consensus for Q2 2025 is expected to be flat at $0.00, compared to a loss of $0.02 in the same quarter last year [3] - For the current year, the earnings estimate is $0.10, with a significant year-over-year growth of 150% expected for the next year at $0.28 [3] Market Performance - ALLT's stock has increased by 28% year-to-date, significantly outperforming the industry growth of 19% [10] - The current valuation metrics indicate that ALLT is trading at a trailing EV-to-EBITDA of 71.63X, which is considerably higher than the industry average of 35.85X [11] Strategic Positioning - The company is benefiting from rising high-margin recurring revenues from its SECaaS offerings, which are expected to grow around 50% year-over-year [8] - Partnerships, such as Verizon's integration of SECaaS into mobile plans, are enhancing recurring revenue visibility and long-term growth potential [6][13] - The competitive landscape includes companies like Radware and Ceragon Networks, which are also focusing on subscription-based services and recurring revenue strategies [9]
STEM Shares Gains 12% on Narrower Q2 Loss, Revenues Increased Y/Y
ZACKS· 2025-08-12 17:01
Core Insights - Stem (STEM) shares have increased by 11.9% following the release of its second-quarter 2025 results, driven by strong growth in software and managed services, new customer engagements, expanded professional services, and increased recurring revenue momentum [1][9] - The company reported a loss of $3.73 per share, which is an improvement from the $4.40 loss per share in the same quarter last year, although it missed the Zacks Consensus Estimate by 24.33% [1][9] Revenue Performance - Revenues for the second quarter of 2025 reached $38.4 million, marking a 12.9% year-over-year increase and surpassing the consensus estimate by 15.93% [2][9] - Solar Software revenues accounted for 24.8% of total revenues, increasing by 20.4% year over year to $9.5 million [3] - Edge Hardware, which made up 31.5% of revenues, saw an 8.6% year-over-year increase to $12.1 million [3] - Project and Professional Services surged by 76.1% year over year to $2.3 million, while Storage Software & Managed Services rose by 53.2% to $9 million [3] - Battery Hardware resale revenues decreased by 30% year over year to $5.4 million [3] Operational Metrics - Bookings for the second quarter were $34.3 million, slightly down from $34.5 million in the previous quarter, while contracted backlog increased by 6% to $26.8 million [4] - Storage operating assets under management (AUM) grew by 42% year over year to 1.7 gigawatt hours (GWh), and solar operating AUM increased by 22% to 32.7 gigawatts (GW) [4] - Contracted Annual Recurring Revenue remained stable at $69.2 million, while Annual Recurring Revenue (ARR) rose by 3% quarter over quarter to $58.5 million, reflecting a 22% year-over-year growth [5] Cost and Margin Analysis - Non-GAAP gross margin expanded by 900 basis points to 48.9% in the second quarter of 2025 [6][9] - Operating expenses decreased significantly by 95.6% year over year to $26.1 million, with research & development expenses down by 34.6% to $10 million, general & administrative expenses down by 43.8% to $8.9 million, and selling and marketing expenses down by 33.8% to $7.3 million [6] EBITDA and Cash Flow - Adjusted EBITDA for the second quarter reached $3.8 million, a significant improvement from an adjusted EBITDA loss of $11.3 million in the same quarter of 2024 [7] - As of June 30, 2025, Stem had cash and cash equivalents of $40.8 million, down from $58.6 million as of March 31, 2025 [8] - Operating cash outflow for the second quarter was $21.3 million, compared to $11.9 million in the second quarter of 2024 [8] Future Guidance - For 2025, Stem expects revenues to be between $125 million and $175 million, with software, edge hardware, and services projected to contribute between $120 million and $140 million [10] - Battery hardware resale is anticipated to be approximately $35 million, with a non-GAAP gross margin expected between 30% and 40% [10] - Adjusted EBITDA is projected to range from a loss of $10 million to a gain of $5 million, and year-end ARR is expected to be between $55 million and $65 million [10]
DarioHealth(DRIO) - 2025 Q2 - Earnings Call Transcript
2025-08-12 13:30
Financial Data and Key Metrics Changes - Total revenues for Q2 2025 were $5.4 million, down from $6.3 million in Q2 2024 and $6.8 million in Q1 2025, reflecting a decline due to the non-renewal of a large national health plan and a strategic shift towards a SaaS-like revenue model [29][30] - GAAP gross margin increased to 65% from 44% year over year, while non-GAAP gross margin was maintained at around 80% in the core B2B2C channel [10][30] - Operating expenses were reduced by 36% to $12.2 million from $18.9 million in Q2 2024, resulting in a narrowed operating loss of $9.2 million, down from $16.2 million [30] Business Line Data and Key Metrics Changes - The company signed 21 new clients year-to-date, with 80% of these accounts focused on multi-condition programs, aligning with the company's strategy [8][12] - Committed annual recurring revenue (CARR) increased by $5 million, with a pipeline totaling $53 million, indicating strong future revenue potential [9][17] - The B2B2C business continues to operate at over 80% gross margins on a non-GAAP basis, demonstrating the efficiency of the business model [10][30] Market Data and Key Metrics Changes - The company serves over 100 clients, including four national health plans and six regional health plans, indicating a diversified client base [13] - The pipeline includes more than 25 qualified health plans for 2026, a significant increase from three health plans in the pipeline a year ago [19] - The company is expanding into the $150 billion sleep health market through a partnership, which is expected to enhance its multi-condition model [21] Company Strategy and Development Direction - The company is focusing on sustainable annual recurring revenue (ARR) growth, emphasizing the importance of differentiated solutions and disciplined execution [12] - The strategy includes leveraging AI to enhance operational efficiency and member engagement, which is expected to reduce operating expenses by 15% over the next year [36] - The company aims to build a scalable financial profile with a clear pathway to cash flow positivity, focusing on high-margin, recurring revenues [32][36] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that Q2 revenues were below expectations due to short-term headwinds but expressed confidence in the company's growth trajectory and the quality of new client acquisitions [7][8] - The company is optimistic about closing the revenue gap and accelerating growth, supported by strong metrics in client quality and recurring revenues [10][11] - Management highlighted the importance of AI in driving future growth and operational efficiency, positioning the company as a leader in the digital health space [36] Other Important Information - The company has undergone a full review of its channel partner network, resulting in revitalized partnerships and a stronger value proposition [15] - The company is transitioning from one-time revenues to recurring revenues, which is expected to enhance long-term financial stability [20] - The company ended Q2 2025 with $22.1 million in cash and short-term deposits, bolstered by recent debt restructuring [30] Q&A Session Summary Question: Was there any churn that contributed to the revenue decline in Q2? - Management confirmed that there was no churn in annual recurring revenue, attributing the decline primarily to the non-renewal of a large health plan contract [39][40] Question: Can you provide more details on the services that the health plan decided to discontinue? - The health plan discontinued a Medicaid maternity program, opting to insource it, which was not a reflection of the company's performance [42][43] Question: What differentiates the current health plan reductions from future wins? - Management clarified that the non-renewal was an isolated incident and emphasized the diversification of their client base, with new significant accounts being signed [46][48] Question: Can you elaborate on the restructuring of the partnership program? - The company is focusing on strategic partnerships to enhance service offerings without expanding internal capabilities, particularly in areas like sleep health [49][50] Question: What are the expectations for operating expenses in the next 12 to 15 months? - Management anticipates a 15% reduction in operating expenses, aiming for quarterly expenses to be around $8 million by the end of next year [52][53] Question: What benefits does the claims-based billing infrastructure provide? - The addition of claims-based billing allows the company to tap into a larger profit pool by rendering services as claims, which is a significant shift from the current administrative budget billing [58][60]
NCR Voyix Corp(VYX) - 2025 Q2 - Earnings Call Presentation
2025-08-07 12:00
Q2 2025 Financial Performance - Revenue for Q2 2025 was $422 million recurring and $244 million non-recurring[14] - Adjusted EBITDA for Q2 2025 was $95 million, a 20% increase compared to Q2 2024[14] - Diluted EPS for Q2 2025 was $(0.02), while Non-GAAP Diluted EPS was $0.19[14] - Recurring revenue increased by 4% in Q2 2025[14] YTD Q2 2025 Financial Performance - YTD Q2 2025 recurring revenue was $829 million, while non-recurring revenue was $454 million[27] - YTD Q2 2025 Adjusted EBITDA was $170 million, a 20% increase compared to YTD Q2 2024[27] - YTD Q2 2025 Diluted EPS was $(0.19), while Non-GAAP Diluted EPS was $0.27[27] - Recurring revenue increased by 3% YTD Q2 2025[27] FY 2025 Outlook - The company projects total revenue between $2575 million and $2650 million for FY 2025[21] - The company projects adjusted EBITDA between $420 million and $445 million for FY 2025[21] - The company projects non-GAAP diluted EPS between $0.75 and $0.80 for FY 2025[21]
Itron (ITRI) Q2 EPS Jumps 34%
The Motley Fool· 2025-08-02 05:44
Core Insights - Itron reported a significant earnings beat with non-GAAP earnings per share at $1.62, exceeding analyst estimates of $1.35, while GAAP revenue was slightly below expectations at $607 million, down from $609 million year-over-year [1][2][5] Financial Performance - Non-GAAP EPS increased by 33.9% year-over-year from $1.21 in Q2 2024 to $1.62 in Q2 2025 [2] - GAAP revenue was $607 million, a decrease of 0.3% from $609 million in Q2 2024 [2] - Gross margin improved to 36.9%, up 2.3 percentage points from 34.6% in Q2 2024 [2][8] - Free cash flow more than doubled to $91 million from $45 million in Q2 2024, reflecting a 102.2% increase [2] - Adjusted EBITDA grew by 16.9% year-over-year to $90 million [2] Business Segments - Device Solutions revenue declined by 5% due to lower legacy electricity product sales, partially offset by increased water sales [5] - Networked Solutions revenue saw a 1% decline, attributed to shipment timing and the absence of one-time revenue recognized in Q2 2024 [5] - Outcomes segment, which includes utility software and data analytics, grew by 9% year-over-year, with a gross margin of 39.2% [6] Strategic Focus - Itron is focusing on technological innovation, investing in research and development for edge intelligence hardware and software applications [4] - The company emphasizes software and recurring revenue as key components of its value proposition, alongside supply chain management and strategic partnerships [4] Operational Highlights - The company achieved record profitability in Q2 2025, with a significant increase in cash and equivalents year-to-date [8] - Total long-term debt was reduced, enhancing the balance sheet, while the backlog rose to $4.5 billion, providing medium-term revenue visibility [9] Future Outlook - Itron updated its FY2025 guidance, projecting revenue between $2.35 billion and $2.4 billion and non-GAAP diluted EPS between $6.00 and $6.20 [10] - For Q3 2025, expected revenue is between $570 million and $585 million, with non-GAAP diluted EPS between $1.45 and $1.55 [10]
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
ZACKS· 2025-07-28 17:40
Core Insights - GE HealthCare Technologies Inc. (GEHC) is set to report its second-quarter 2025 results on July 30, with a history of earnings surprises, averaging 8.92% over the last four quarters [1][2] Q2 Estimates - The Zacks Consensus Estimate for revenues is $4.97 billion, indicating a year-over-year growth of 2.8% [2] - The estimated earnings per share (EPS) is $0.91, reflecting a decline of 9% compared to the previous year [2] Segmental Overview - The Imaging segment is crucial for revenue and margin growth, achieving 5% organic revenue growth in Q1, primarily in the U.S., with a 130-basis point EBIT margin expansion [3] - Advanced Visualization Solutions (AVS) reported 3% organic revenue growth in Q1, driven by the U.S. market, with a slight EBIT margin increase of 10 basis points [4] - Patient Care Solutions (PCS) saw 2% organic growth in Q1, but EBIT margin declined by 450 basis points due to tariffs and unfavorable product mix [5] - Pharmaceutical Diagnostics (PDx) excelled with 8% organic revenue growth and maintained an EBIT margin above 32%, bolstered by increased procedure volumes and positive pricing dynamics [6] Other Factors to Note - Tariffs are a significant concern, with an expected adjusted EPS drag of approximately $0.85 for the full year and nearly $100 million impact anticipated in Q2 [7][8] - The company has implemented mitigation strategies but expects ongoing challenges from high-cost inventory [8] - Innovation is a key focus, with the launch of Flyrcado and plans for regulatory submission of a photon-counting CT system later this year [9]
Moody’s(MCO) - 2025 Q2 - Earnings Call Presentation
2025-07-23 13:00
Financial Performance Highlights - Moody's achieved its second-highest Q2 revenue on record[9] - Moody's Analytics (MA) Annualized Recurring Revenue (ARR) reached $33 billion, an increase of 8% year-over-year[9] - Adjusted Operating Margin increased by 130 basis points to 509%[12] - Adjusted Diluted EPS increased by 9% to $356[12] Moody's Investors Service (MIS) Performance - MIS revenue outpaced issuance by approximately 12%[13] - MIS achieved an Adjusted Operating Margin of 642%, up 100 basis points[12, 16] - Total MIS rated issuance guidance was updated to reflect a decrease in the low-single-digit to mid-single-digit percent range[27, 36] Moody's Analytics (MA) Performance - MA experienced strong recurring revenue growth, with recurring revenue accounting for 96% of total revenue[19] - MA's Adjusted Operating Margin increased by 360 basis points to 321%[12, 19] - Decision Solutions led with 10% ARR growth[12] - MA revenue grew by 11% year-over-year[19] Updated Full Year 2025 Guidance - MCO revenue growth is projected to be in the mid-single-digit percent range[10] - Adjusted Diluted EPS is now expected to be in the range of $1350 to $1400[12] - The company plans to repurchase at least $13 billion in shares[39]
MSCI(MSCI) - 2025 Q2 - Earnings Call Presentation
2025-07-22 15:00
Second Quarter 2025 Earnings Presentation July 22, 2025 © 2025 MSCI Inc. All rights reserved. Introduction → Forward-Looking Statements 2 → This earnings presentation contains forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, MSCI's Full-Year 2025 guidance and MSCI's long-term targets. These forward-looking statements relate to future events or to future financial performance and involve underlying assumptions, as well as kn ...
NAPCO Security Technologies(NSSC) - 2018 Q4 - Earnings Call Presentation
2025-07-04 14:04
Company Overview - NAPCO is a leader in commercial & residential security products with over 10,000 dealers, integrators & distributors in the US[5] - The company has two dozen patents and proprietary software[5] - The company is shifting towards recurring revenue and school security[5] Financial Highlights - Fiscal Fourth Quarter 2018 sales reached a record of $27.3 million, a 6% increase[48] - Recurring revenue increased by 49%[48] - Recurring revenue annual run rate is $14.7 million as of July 2018[48, 67] - TTM Revenue of $91.7 million with zero debt[67] - EPS up from $0.17 to $0.20[48] Market Opportunity - The company addresses both commercial (80%) and residential (20%) markets[8] - The company provides solutions for school security, addressing a market of 100,000 K-12 schools and 10,000 campuses[41] Stock Information - Market Capitalization is $284.0 million[66] - Insider Ownership is 38%[66, 67]
NAPCO Security Technologies(NSSC) - 2020 Q4 - Earnings Call Presentation
2025-07-04 14:03
Company Overview - NAPCO is a leader in designing and manufacturing commercial & residential security products, selling through 10,000+ dealers, integrators & distributors in the US [5] - The company has two major growth drivers: recurring revenue and school security [5] - NAPCO is the only company with products in all three security verticals: Alarms & Connectivity, Locking, and Access Control [34] Financial Performance - FY 2020 sales reached $101.3 million [43] - FY 2020 recurring revenue increased by 38% [43] - Recurring Revenue Annual Run Rate is at $27.5 million [43] - FY 2020 RMR Gross Margin was 82% [43] - The company has a cash balance of $18.2 million and zero debt [43] - Adjusted EBITDA for FY 2020 was $14.7 million [43] Market and Growth Opportunities - The company estimates a commercial market of 5 million buildings [39] - The company estimates a residential market of 120 million homes [41] - School security is a major growth driver, with increased funding, for example, Florida $500 million and Wisconsin $100 million [18, 21]